To support further the relevance of RNA-seq and metabolomic profiling results to both mouse and human disease, we then conducted parallel functional metabolic assays both in mouse (LSK) and human (CD34+CD38−) LSC-enriched cell populations harvested respectively from CP and BC CML mice and patients. This evidence concerns the gene CD38 and chronic myelogenous leukemia, BCR-ABL1 positive.